Results 181 to 190 of about 2,522,370 (217)

Zoledronic Acid in the Treatment of Primary Knee Osteoarthritis: A Randomized Clinical Trial. [PDF]

Cureus
Ealahi T, Azad MAK, Islam MN, Hassan MM, Ferdous N, Rashid FB, Tazbir A.   +6 more
europepmc   +1 more source

Cardiovascular adverse events associated with denosumab versus zoledronic acid in patients with breast cancer: a propensity score overlap weighted analysis. [PDF]

Breast Cancer Res Treat
Iwai C, Konishi T, Miyawaki A, Okada A, Isogai T, Jo T, Yasunaga H.   +6 more
europepmc   +1 more source

Efficacy, safety and economy of denosumab and zoledronic acid in the treatment of bone metastases of solid tumors and multiple myeloma: a systematic review and meta-analysis. [PDF]

Front Oncol
Zhong L, Chen W, Zheng D, Cao Y, Zhu L, Zhu Z, Liao L, Dai L, Wang X, Zeng Z.   +9 more
europepmc   +1 more source

Corrigendum to "Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial" [J. Bone Oncol. 35 (2022) 100441]. [PDF]

J Bone Oncol
Yue J, Sun W, Li S.
europepmc   +1 more source

Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer. [PDF]

Breast
Zecca E, Zambelli L, Tinè G, Bracchi P, Miceli R, Pigni A, Lo Dico S, Ricchini F, Mariani G, Massa G, Caraceni A.   +10 more
europepmc   +1 more source

Estrogen prevents anti-tumor effects of Zoledronic acid in breast cancer through the NK and CD8+T cell PD-1/PD-L1 axes

George C, Zhou J, Canuas-Landero V, Lefley D, Hughes R, Thistletwaite F, Wilson C, Holen I, Brown J, Dunning M, Danson S, Winter M, Quayle L, Muthana M, Ottewell P.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Zoledronic acid

Expert Opinion on Drug Safety, 2010
Both bone metastases and fragility fractures due to bone loss result in considerable morbidity affecting quality of life and independence as well as placing complex demands on healthcare resources. Zoledronic acid is a widely used intravenous bisphosphonate that reduces this skeletal morbidity in both benign and malignant conditions.The incidence ...
Robert, Coleman, Roger, Burkinshaw, Matthew, Winter, Helen, Neville-Webbe, Jim, Lester, Emma, Woodward, Janet, Brown   +6 more
  +7 more sources

Zoledronic Acid

Drugs, 2001
Zoledronic acid (zoledronate) is a new generation bisphosphonate that inhibits osteoclast bone resorption. It was much more potent than other bisphosphonates at inhibiting 1,25-dihydroxyvitamin D3-induced hypercalcaemia in a rat model and calcium release in vitro.
S M, Cheer, S, Noble
openaire   +2 more sources